Press release
Pharmacovigilance (PV) Market With Covid-19 Impact and Market Size, Share, Growth Factors, Competitive Landscape and Regional Forecast 2031 | Linical Accelovance, Cognizant, IBM Corporation, ArisGlobal
New York, According to a new market research report published by Global Insight Services Pharmacovigilance (PV) Market is expected to grow by 2031. Report includes in-depth segmentation and market size data by categories, product types, applications, and geographies. Report also includes comprehensive analysis of key issues, trends and drivers, restraints and challenges, competitive landscape, as well as recent events such as M&A activities in the market.Request Sample Report : https://www.globalinsightservices.com/request-sample/GIS22087
Pharmacovigilance is the science and activities related to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problems.
Passive surveillance is the most common type of pharmacovigilance activity. It is important because it can identify previously unknown adverse events. However, it has some limitations, such as under-reporting and reporting bias.
Active surveillance is less common, but it is useful for monitoring drugs that are used to treat rare conditions. Experimental studies are the most reliable way to assess the safety of a new medicine, but they are usually only conducted during the development and approval process.
Key Trends
There are several key trends in PV technology:
1. The use of big data and machine learning to identify potential safety risks.
2. The use of predictive analytics to identify at-risk patients.
3. The use of social media monitoring to identify potential safety concerns.
4. The use of mobile technology to collect patient-reported data.
Key Drivers
The key drivers of pharmacovigilance (PV) market are the increasing number of clinical trials, the growing prevalence of chronic and life-threatening diseases, and the need for better patient safety.
The number of clinical trials has been increasing over the years as the pharmaceutical industry seeks to develop new and better treatments for various diseases. This has led to an increase in the number of patients being exposed to new drugs, which has in turn led to an increase in the need for PV.
The prevalence of chronic and life-threatening diseases is also a key driver of the PV market. As the population ages, the number of people suffering from chronic diseases such as cancer and heart disease is increasing. This is leading to a greater need for PV, as these patients are often taking multiple medications that need to be closely monitored for safety.
Read Full Research Report : https://www.globalinsightservices.com/reports/pharmacovigilance-pv-market
Key Market Segments
The pharmacovigilance (PV) bifurcated on the basis of type, service provider, end-user, and region. On the basis of type, it is segmented into adverse drug reaction capture (ADR), case processing, reporting & submission, and others. By service provider, it is divided into up to contract research organization and business processing outsourcing. By end-user, it is analyzed across pharmaceutical industry, research organization, and others. Region-wise, it is studied across North America, Europe, Asia-Pacific, and rest of the World.
Key Market Players
The pharmacovigilance (PV) market report includes players such as Linical Accelovance, Cognizant, IBM Corporation, ArisGlobal, ICON plc., Capgemini, ITClinical, FMD K&L, and IQVIA.
Buy Now : https://www.globalinsightservices.com/checkout/single_user/GIS22087
Reasons to buy Pharmacovigilance (PV) Market Report:
• Develop comprehensive understanding of market landscape - industry structure, value-chain, key players, trends, drivers, and challenges
• Drive revenue and market-entry strategy by gaining insights into which segments and geographies are largest and likely to grow fastest
• Formulate sales and marketing strategies by gaining understanding of competitors, their positioning, and strengths & weaknesses
• Develop business and M&A strategies through understanding of latest trends and emerging players in the market
• Refine your business plans by understanding impact of disruptions such as Covid-19 and Russia-Ukraine conflict on the market
New Report Published by Global Insight Services : https://www.globalinsightservices.com/reports/hydrogen-projects-database/
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pharmacovigilance (PV) Market With Covid-19 Impact and Market Size, Share, Growth Factors, Competitive Landscape and Regional Forecast 2031 | Linical Accelovance, Cognizant, IBM Corporation, ArisGlobal here
News-ID: 3036493 • Views: …
More Releases from Global Insight Services

Risk Management Software Market Is Anticipated To Expand From $14.9 Billion In 2 …
Market Overview
The Risk Management Software Market is becoming an essential pillar for organizations across industries as they navigate an increasingly complex business environment. Companies face rising challenges ranging from regulatory compliance and cybersecurity threats to operational inefficiencies and supply chain disruptions. Risk management software provides a unified solution to identify, monitor, and mitigate these risks, enabling organizations to make informed decisions while safeguarding business continuity. These tools are not limited…

Rare Disease Treatment Market Expected to Grow from $213.5 Billion in 2024 to $5 …
The Rare Disease Treatment Market is emerging as one of the most dynamic sectors in the global healthcare landscape. This market focuses on the development, production, and distribution of therapies designed to address rare and complex medical conditions affecting a small percentage of the population. Rare diseases, often genetic in origin, pose significant treatment challenges, which has prompted biopharmaceutical companies to invest in innovative solutions such as orphan drugs, gene…

Digital Health Coaching Market Expected to Grow from $10.7 Billion in 2024 to $3 …
The Digital Health Coaching Market is revolutionizing the healthcare and wellness landscape by offering personalized guidance through digital platforms. This market encompasses mobile applications, web-based platforms, and wearable devices that integrate artificial intelligence, data analytics, and behavioral science to provide tailored health programs. From chronic disease management to mental health support and nutrition coaching, digital health coaching empowers individuals to achieve their health goals conveniently and efficiently. The growing emphasis…

Real-world Evidence (Rwe) Market Is Anticipated To Expand From $18.6 Billion In …
Market Overview
The Real-World Evidence (RWE) Market is becoming a cornerstone of modern healthcare, revolutionizing the way data is used to inform treatment decisions, drug development, and regulatory approvals. Unlike traditional clinical trials, which are conducted under controlled conditions, real-world evidence captures insights from everyday healthcare settings such as electronic health records, insurance claims, patient registries, and wearable devices. This approach provides a more comprehensive picture of how therapies perform in…
More Releases for Pharmacovigilance
Top Pharmacovigilance Companies Analysis By 2031
The Pharmacovigilance Market is expected to register a CAGR of 6.6% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.
Download PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00003127?utm_source=OpenPR&utm_medium=10379
The List of Companies
• #Accentures
• Bristol-Myers Squibb Company
• Linical Accelovance
• Cognizant
• Covance Inc.
• F. Hoffmann-La Roche Ltd.
• GlaxoSmithKline plc.
• ICON plc
• Capgemini (IGATE Corporation)
Clinical…
Pharmacovigilance - Scope and Research Methodology
The Pharmacovigilance Market is expected to register a CAGR of 6.6% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.
The Pharmacovigilance Market report covers analysis by Clinical Trial Phase (Pre-Clinical, Phase I, Phase II, Phase III, and Phase IV), Service Provider (In-House and Contract Outsourcing), Type of Method (Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event…
Pharmacovigilance World 2025 Conference & Expo
We are delighted to welcome you to the Pharmacovigilance World 2025, and we are confident that your active participation will contribute to the advancement of drug safety practices. Together, let us strive towards a safer and more vigilant healthcare system that prioritizes patient well-being and ensures the continued benefit of medications worldwide.
As medical science advances, so does our understanding of drug safety and the need for vigilance when it comes…
Top Factor Driving Pharmacovigilance Market Growth in 2025: Research And Develop …
How Are the key drivers contributing to the expansion of the pharmacovigilance market?
The escalation in research and development undertakings stimulates growth in the pharmacovigilance market. Pharmaceutical organizations can create novel and superior drugs through enhanced safety profiles by allocating resources to R&D. The intensive testing in preclinical and clinical stages during the drug development protocol allows early recognition of potential safety issues, paving the way for adequate risk reduction approaches.…
Monitoring Medication Safety with Pharmacovigilance
Pharmacovigilance (PV) is defined as the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem. Pharmacovigilance plays a significant role in pharmaceutical and biotechnological sectors in designing of drugs and their interactions. The pharmacovigilance involves collecting information from healthcare providers and patients to know about the hazards associated with medications.
Download Sample PDF at: https://www.theinsightpartners.com/sample/TIPRE00003127?utm_source=OpnePR&utm_medium=10776
Increasing cases of adverse drug reactions…
Pharmacovigilance Market Opportunity Analysis by 2028
Pharmacovigilance Market: Introduction
According to the report, the global pharmacovigilance market was valued at US$ 6.1 Bn in 2020 and is projected to expand at a CAGR of 8.8% from 2021 to 2028. Pharmacovigilance activities are defined as science used for detection, assessment, understanding, and prevention of adverse effects of drugs and vaccines. Drugs and vaccines go through rigorous testing in the clinical trials to check their safety and efficacy before…